PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
22-Jan-2024 Priory nominated for Health Tech Awards after Nourish digital records system saves 80,000 staff hours Nourish Care
18-Jan-2024 Verseon Gain US Patent Protection for Compounds that Could Eliminate Bleeding Risks of Current Anticoagulants Verseon
18-Jan-2024 Aptar Digital Health and Moffitt Cancer Center Launch Clinical Evaluation for Oncology Digital Therapeutic, Oleena® Aptar Digital Health
18-Jan-2024 More Than 350 Companies Increase Efficiency and Compliance with Veeva Training Solutions Veeva
18-Jan-2024 Oxford BioTherapeutics Announces First Patient Dosed with OBT076 in Phase 1b Trial in Adenoid Cystic Carcinomas of the Head and Neck Oxford BioTherapeutics
18-Jan-2024 Synendos Therapeutics AG Granted EMA Clinical Trial Authorisation for first-in-class Endocannabinoid System modulator, SYT-510 Synendos Therapeutics
18-Jan-2024 UK maintains its position as an attractive destination for advanced therapy clinical trials The Cell and Gene Therapy Catapult (CGT Catapult),
16-Jan-2024 TrakCel launches Consultancy Services to share extensive cell and gene therapy process development expertise TrakCel
16-Jan-2024 CellQuest launches Early Access Program with first CosyNest automated CAR-T manufacturing partner CellQuest
16-Jan-2024 Theriva Biologics to Participate in the B. Riley Securities Annual Oncology Conference Theriva Biologics, Inc
16-Jan-2024 CellQuest launches Early Access Program with first CosyNest automated CAR-T manufacturing partner CellQuest
16-Jan-2024 Phesi releases 2023 analysis of clinical development; breast cancer remains most studied disease area for third year Phesi
16-Jan-2024 Modular automation solution adds PACE to just-in-time clinical trials packing CME Automation Systems
13-Jan-2024 Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner Avance Clinical
12-Jan-2024 HUTCHMED Announces NDA Acceptance in China for Sovleplenib for the Treatment of Primary Immune Thrombocytopenia with Priority Review Status HUTCHMED
10-Jan-2024 Spago Nanomedical proceeds to the next dose level in the phase I/IIa study Tumorad-01 Spago Nanomedical AB (publ)
10-Jan-2024 Ariceum Therapeutics files for UK Clinical Trial Authorisation (CTA) to test its First-in-Class Iodine-123 labelled PARP inhibitor in patients with recurrent glioblastoma Ariceum Therapeutics
10-Jan-2024 AbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for People Living with Advanced Parkinson's Disease in the European Union AbbVie
09-Jan-2024 CD Biosciences Launches Substrate-Chromogens for Immunohistochemistry CD Biosciences
09-Jan-2024 STEMart Launches New Force Degradation Services to Ensure Drug Stability and Safety STEMart